Chris Hill is a finance professional with extensive experience in leadership roles within the biotechnology and pharmaceutical sectors. Currently serving as Consultant CFO at Adaptimmune since September 2025 and as Chief Financial Officer at Istesso since September 2021, Chris has previously held significant positions, including Director of Finance at OxSonics Therapeutics from June 2019 to September 2021, and Group CFO at Oxford Pharmascience Ltd from January 2014 to January 2017. Earlier experience includes serving as Group Financial Controller at ORA Capital Partners and Auditor at Grant Thornton. Chris holds a degree in Economics from Leeds Beckett University, completed between 1998 and 2001, and attended Pocklington School from 1992 to 1998.
This person is not in the org chart
This person is not in any teams
This person is not in any offices